BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 2894018)

  • 21. Evidence for histamine H1 and H2 receptors in guinea-pig oxyntic cells.
    Vinik AI; Heldsinger AA; Skoglund ML
    J Pharmacol Exp Ther; 1983 Oct; 227(1):115-21. PubMed ID: 6137553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Central action of narcotic analgesics. Part IV. Noradrenergic influences on the activity of analgesics in rats.
    Malec D; Grabowska E; Langwiński R
    Pol J Pharmacol Pharm; 1978; 30(5):627-37. PubMed ID: 35781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. H1 and H2 histamine receptors modulate osteoclastic resorption by different pathways: evidence obtained by using receptor antagonists in a rat synchronized resorption model.
    Dobigny C; Saffar JL
    J Cell Physiol; 1997 Oct; 173(1):10-8. PubMed ID: 9326444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Central action of narcotic analgesics. VIII. The effect of dopaminergic stimulants on the action of analgesics in rats.
    Malec D; Langwiński R
    Pol J Pharmacol Pharm; 1981 Oct; 33(3):273-82. PubMed ID: 6119681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of H1 and H2 receptor blockers on mobilization of myocardial carnosine to histamine during compound 48/80-induced shock in young rats.
    Fitzpatrick JC; Fisher H; Flancbaum L
    Circ Shock; 1990 Feb; 30(2):145-53. PubMed ID: 1968787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study on the antinociceptive action of Tyr-K-MIF-1, a peptide from the MIF family.
    Zamfirova R; Bocheva A; Dobrinova Y; Todorov S
    Auton Autacoid Pharmacol; 2007 Apr; 27(2):93-8. PubMed ID: 17391278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroprotective effects of hibernation-regulating substances against low-temperature-induced cell death in cultured hamster hippocampal neurons.
    Tamura Y; Monden M; Shintani M; Kawai A; Shiomi H
    Brain Res; 2006 Sep; 1108(1):107-16. PubMed ID: 16854391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of benzodiazepines on the central action of narcotic analgesics.
    Matla J; Langwiński R
    Pol J Pharmacol Pharm; 1982; 34(1-3):135-44. PubMed ID: 6132369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced antinociceptive effects of morphine in histamine H2 receptor gene knockout mice.
    Mobarakeh JI; Takahashi K; Sakurada S; Kuramasu A; Yanai K
    Neuropharmacology; 2006 Sep; 51(3):612-22. PubMed ID: 16806305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracerebroventricular effects of histaminergic agents on morphine-induced anxiolysis in the elevated plus-maze in rats.
    Zarrindast MR; Rostami P; Zarei M; Roohbakhsh A
    Basic Clin Pharmacol Toxicol; 2005 Nov; 97(5):276-81. PubMed ID: 16236138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of histamine and H1 and H2-receptor antagonists on wet-dog-shake episodes in rats induced with tranylcypromine and 5-methoxytryptamine.
    Kolasa K; Kleinrok Z; Rajtar G; Juszkiewicz M
    Acta Physiol Pol; 1984; 35(3):225-30. PubMed ID: 6152672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antinociceptive effect of intracerebroventricularly administered histamine in rats.
    Bhattacharya SK; Parmar SS
    Res Commun Chem Pathol Pharmacol; 1985 Jul; 49(1):125-36. PubMed ID: 4035075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Central action of narcotic analgesics. V. Participation of serotonin in the mechanism of action of narcotic analgesics.
    Fidecka S; Langwiński R
    Pol J Pharmacol Pharm; 1979; 31(5):461-71. PubMed ID: 44745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of histamine on intracortical blood vessels of rats].
    Zhao JJ; Liu Y; Chen XL; Liu JX; Tian YF; Zhang PB; Kang QY; Qiu F; Yang PB
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Sep; 26(9):1284-7. PubMed ID: 16982436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of intracerebroventricular injection of histamine and its related compounds on rectal temperature in mice.
    Chen Z; Sugimoto Y; Kamei C
    Methods Find Exp Clin Pharmacol; 1995 Dec; 17(10):669-75. PubMed ID: 9053587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antinociceptive, brain-penetrating derivatives related to improgan, a non-opioid analgesic.
    Hough LB; Nalwalk JW; Lu Q; Shan Z; Svokos K; Wentland MP; Montero MJ
    Eur J Pharmacol; 2005 Oct; 522(1-3):38-46. PubMed ID: 16216240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potentiation of opioid analgesia by H1 and H2 antagonists.
    Bluhm R; Zsigmond EK; Winnie AP
    Life Sci; 1982 Sep 20-27; 31(12-13):1229-32. PubMed ID: 6128651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stereoselective and calcium-dependent contractile effects of narcotic antagonist analgesics in the vascular smooth muscle of the rat.
    Lee CH; Berkowitz BA
    J Pharmacol Exp Ther; 1976 Aug; 198(2):347-56. PubMed ID: 7664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antinociception induced by central administration of histamine in the formalin test in rats.
    Mojtahedin A; Tamaddonfard E; Zanboori A
    Indian J Physiol Pharmacol; 2008; 52(3):249-54. PubMed ID: 19552055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancement mu opioid antinociception by oral delta9-tetrahydrocannabinol: dose-response analysis and receptor identification.
    Cichewicz DL; Martin ZL; Smith FL; Welch SP
    J Pharmacol Exp Ther; 1999 May; 289(2):859-67. PubMed ID: 10215664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.